DYN
Price
$13.15
Change
+$0.57 (+4.53%)
Updated
Sep 26 closing price
Capitalization
1.87B
33 days until earnings call
NXTC
Price
$5.70
Change
-$0.08 (-1.38%)
Updated
Sep 26 closing price
Capitalization
15.25M
33 days until earnings call
Interact to see
Advertisement

DYN vs NXTC

Header iconDYN vs NXTC Comparison
Open Charts DYN vs NXTCBanner chart's image
Dyne Therapeutics
Price$13.15
Change+$0.57 (+4.53%)
Volume$1.4M
Capitalization1.87B
NextCure
Price$5.70
Change-$0.08 (-1.38%)
Volume$9.47K
Capitalization15.25M
DYN vs NXTC Comparison Chart in %
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. NXTC commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and NXTC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (DYN: $13.15 vs. NXTC: $5.70)
Brand notoriety: DYN and NXTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 52% vs. NXTC: 7%
Market capitalization -- DYN: $1.87B vs. NXTC: $15.25M
DYN [@Biotechnology] is valued at $1.87B. NXTC’s [@Biotechnology] market capitalization is $15.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileNXTC’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • NXTC’s FA Score: 1 green, 4 red.
According to our system of comparison, both DYN and NXTC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish while NXTC’s TA Score has 6 bullish TA indicator(s).

  • DYN’s TA Score: 5 bullish, 3 bearish.
  • NXTC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both DYN and NXTC are a good buy in the short-term.

Price Growth

DYN (@Biotechnology) experienced а +0.15% price change this week, while NXTC (@Biotechnology) price change was +1.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

DYN is expected to report earnings on Oct 30, 2025.

NXTC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.87B) has a higher market cap than NXTC($15.3M). NXTC YTD gains are higher at: -38.392 vs. DYN (-44.185). NXTC has higher annual earnings (EBITDA): -61.2M vs. DYN (-437.37M). DYN has more cash in the bank: 684M vs. NXTC (35.3M). NXTC has less debt than DYN: NXTC (4.67M) vs DYN (121M). DYN (0) and NXTC (0) have equivalent revenues.
DYNNXTCDYN / NXTC
Capitalization1.87B15.3M12,229%
EBITDA-437.37M-61.2M715%
Gain YTD-44.185-38.392115%
P/E RatioN/AN/A-
Revenue00-
Total Cash684M35.3M1,938%
Total Debt121M4.67M2,593%
FUNDAMENTALS RATINGS
NXTC: Fundamental Ratings
NXTC
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNNXTC
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCJX32.57N/A
N/A
MFS Mid Cap Growth R4
HSLTX47.85N/A
N/A
Hartford Small Cap Growth R5
CAMUX22.03N/A
N/A
Cambiar SMID Institutional
NMPAX14.74N/A
N/A
Columbia Mid Cap Index Inst
PGLRX18.31N/A
N/A
Putnam Focused International Equity R

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+4.53%
XNCR - DYN
58%
Loosely correlated
+12.00%
RNA - DYN
58%
Loosely correlated
+5.02%
CRNX - DYN
56%
Loosely correlated
+27.92%
IDYA - DYN
52%
Loosely correlated
+4.52%
SYRE - DYN
52%
Loosely correlated
+4.04%
More

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with ACET. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
-1.38%
ACET - NXTC
34%
Loosely correlated
+0.14%
SRPT - NXTC
31%
Poorly correlated
+3.61%
RARE - NXTC
30%
Poorly correlated
+4.53%
DYN - NXTC
29%
Poorly correlated
+4.53%
LEGN - NXTC
27%
Poorly correlated
+1.68%
More